• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Leveraging the Shared Neurobiology of Placebo Effects and Functional Neurological Disorder: A Call for Research.

作者信息

Burke Matthew J, Faria Vanda, Cappon Davide, Pascual-Leone Alvaro, Kaptchuk Ted J, Santarnecchi Emiliano

机构信息

Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston (Burke, Cappon, Pascual-Leone, Santarnecchi); the Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston (Burke, Faria, Kaptchuk); the Department of Psychiatry, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto (Burke); the Department of Otorhinolaryngology, Smell and Taste Clinic, Technische Universität Dresden, Dresden, Germany (Faria); the Department of Psychology, Uppsala University, Uppsala, Sweden (Faria); the Department of Anesthesiology, Perioperative and Pain Medicine, Center for Pain and the Brain, Boston Children's Hospital, Harvard Medical School, Boston (Faria); Institut Guttmann, Universitat Autonoma, Barcelona, Spain (Pascual-Leone); and the Hinda and Arthur Marcus Institute for Aging Research and Center for Memory Health, Hebrew SeniorLife Department of Neurology, Harvard Medical School, Boston (Pascual-Leone).

出版信息

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):101-104. doi: 10.1176/appi.neuropsych.19030077. Epub 2019 Oct 30.

DOI:10.1176/appi.neuropsych.19030077
PMID:31662093
Abstract
摘要

相似文献

1
Leveraging the Shared Neurobiology of Placebo Effects and Functional Neurological Disorder: A Call for Research.利用安慰剂效应和功能性神经障碍的共同神经生物学:研究呼吁
J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):101-104. doi: 10.1176/appi.neuropsych.19030077. Epub 2019 Oct 30.
2
Knowledge Gaps in Placebo Research: With Special Reference to Neurobiology.安慰剂研究中的知识空白:特别参考神经生物学。
Int Rev Neurobiol. 2018;139:85-106. doi: 10.1016/bs.irn.2018.07.018. Epub 2018 Aug 3.
3
Treatment for Patients With a Functional Neurological Disorder (Conversion Disorder): An Integrated Approach.功能性神经障碍(转换障碍)患者的治疗:一种综合方法。
Am J Psychiatry. 2018 Apr 1;175(4):307-314. doi: 10.1176/appi.ajp.2017.17040450.
4
[Assessment and treatment of conversion disorder: the most fascinating borderline of psychiatry and neurology].[转换障碍的评估与治疗:精神病学与神经病学中最具吸引力的边缘领域]
Duodecim. 2012;128(6):634-41.
5
Conversion disorder and mass psychogenic illness in child neurology.儿童神经病学中的转换障碍和群体性心因性疾病。
Ann N Y Acad Sci. 2013 Nov;1304:40-4. doi: 10.1111/nyas.12298. Epub 2013 Oct 18.
6
Functional neurological disorders: the neurological assessment as treatment.功能性神经障碍:作为治疗手段的神经学评估。
Neurophysiol Clin. 2014 Oct;44(4):363-73. doi: 10.1016/j.neucli.2014.01.002. Epub 2014 Feb 22.
7
The use of contingent reinforcement in the treatment of a conversion disorder: a multiple baseline study.在转换障碍治疗中使用偶然强化:一项多基线研究。
J Behav Ther Exp Psychiatry. 1985 Dec;16(4):341-5. doi: 10.1016/0005-7916(85)90009-6.
8
[Conversion disorders. From neurobiology to treatment].[转换障碍。从神经生物学到治疗]
Nervenarzt. 2004 Jul;75(7):619-27. doi: 10.1007/s00115-003-1650-y.
9
Large-field repetitive transcranial magnetic stimulation with circular coil in the treatment of functional neurological symptoms.采用圆形线圈进行大视野重复经颅磁刺激治疗功能性神经症状。
Neurophysiol Clin. 2014 Oct;44(4):425-31. doi: 10.1016/j.neucli.2014.04.004. Epub 2014 May 15.
10
Neurological conversion disorders in childhood.
Lancet. 1991 Apr 13;337(8746):889-90.

引用本文的文献

1
Public and professional attitudes towards deceptive and open-label placebo in functional neurological disorder and wider neurological practice.公众及专业人士对功能性神经障碍及更广泛神经科实践中欺骗性和开放标签安慰剂的态度。
BMJ Neurol Open. 2025 Sep 21;7(2):e001171. doi: 10.1136/bmjno-2025-001171. eCollection 2025.
2
Pilot feasibility randomised controlled trial of cognitive-behavioural therapy for functional cognitive disorder after concussion.脑震荡后功能性认知障碍的认知行为疗法的试点可行性随机对照试验
BMJ Neurol Open. 2024 Oct 11;6(2):e000666. doi: 10.1136/bmjno-2024-000666. eCollection 2024.
3
Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.
低剂量裸盖菇素治疗短暂单侧神经痛样头痛发作:一项开放标签 I b 期递增剂量研究结果。
Headache. 2024 Nov-Dec;64(10):1309-1317. doi: 10.1111/head.14837. Epub 2024 Sep 20.
4
Functional neurological disorder and placebo and nocebo effects: shared mechanisms.功能性神经疾病与安慰剂和反安慰剂效应:共同的机制。
Nat Rev Neurol. 2022 Oct;18(10):624-635. doi: 10.1038/s41582-022-00711-z. Epub 2022 Sep 8.
5
Expectancy in placebo-controlled trials of psychedelics: if so, so what?安慰剂对照试验中对致幻剂的期待:如果是这样,那又怎样?
Psychopharmacology (Berl). 2022 Oct;239(10):3047-3055. doi: 10.1007/s00213-022-06221-6. Epub 2022 Sep 5.
6
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.加拿大情绪和焦虑治疗网络(CANMAT)工作组报告:治疗重度抑郁症的血清素致幻药物治疗。
Can J Psychiatry. 2023 Jan;68(1):5-21. doi: 10.1177/07067437221111371. Epub 2022 Aug 17.